Abstract:An account on the currently limited knowledge generated with a still thin repertoire of genetic/chemical tools on the (patho)physiological roles of the individual deacylase activities of sirtuins is presented, calling for an expanded research to ultimately sort out the (patho)physiological roles of all the deacylase activities indicated in this figure. Since the discovery of the sirtuin family founding member (i.e., the yeast silent information regulator 2 (sir2) protein) in 2000, more and more sirtuin proteins have been identified and are currently known to be present in organisms from all the three kingdoms of life (i.e., bacteria, archaea, and eukarya). Seven sirtuin proteins have been identified in mammals including humans, that is, SIRT1/2/3/4/5/6/7. Sirtuin proteins are a class of enzymes with primary catalytic activity being the β‐nicotinamide adenine dinucleotide (β‐NAD+ or NAD+)‐dependent deacylation from the Nε‐acyl‐lysine residues on cellular proteins. Many sirtuins (e.g., human SIRT1/2/3/4/5/6/7) have been found to each possess multiple individual deacylase activities acting on Nε‐acyl‐lysine substrates with different acyl groups ranging from the simple formyl and acetyl to the more complex groups like succinyl and myristoyl; however, our current knowledge on the (patho)physiological roles of these individual deacylase activities is still limited, which could be due to the currently still thin research toolbox for investigation (i.e., the deacylase‐selective sirtuin mutant and inhibitor/activator). In this article, an updated account on the subject matter will be presented with biochemical and medicinal chemistry perspectives.

Fluorogenic Assays for the Defatty-Acylase Activity of Sirtuins.

A fluorometric assay of SIRT1 deacetylation activity through quantification of nicotinamide adenine dinucleotide.

Specific Turn-On Fluorescent Probe With Aggregation-Induced Emission Characteristics For Sirt1 Modulator Screening And Living-Cell Imaging

Continuous Sirtuin/HDAC (histone deacetylase) activity assay using thioamides as PET (Photoinduced Electron Transfer)-based fluorescence quencher

Sensitive Fluorogenic Substrates for Sirtuin Deacylase Inhibitor Discovery.

A homogeneous time-resolved fluorescence screen to identify SIRT2 deacetylase and defatty-acylase inhibitors

Interactions Between Sirtuins and Fluorogenic Small-Molecule Substrates Offer Insights into Inhibitor Design

Bioluminescence Assay of Lysine Deacylase Sirtuin Activity

A One-Step Specific Assay for Continuous Detection of Sirtuin 2 Activity

Mechanism-based affinity capture of sirtuins.

Deacetylation-activated construction of single quantum dot-based nanosensor for sirtuin 1 assay

Discovery and mechanism study of SIRT1 activators that promote the deacetylation of fluorophore-labeled substrate.

The (patho)physiological roles of the individual deacylase activities of a sirtuin

Simultaneous Inhibition Of Sirt2 Deacetylase And Defatty-Acylase Activities Via A Protac Strategy

Assessment of Mitochondrial Dysfunctions after Sirtuin Inhibition.

Acetylome Study in Mouse Adipocytes Identifies Targets of SIRT1 Deacetylation in Chromatin Organization and RNA Processing.

Interactions of SIRT1 with Acetyl Substrate, NAD+ or Nicotinamide

A Near Infrared Fluorescent Probe for One-Step Detection of Histone Deacetylase Activity Based on an Intramolecular FRET

Activation and inhibition of sirtuins: From bench to bedside

Activatable Fluorescence Probe Via Self-Immolative Intramolecular Cyclization for Histone Deacetylase Imaging in Live Cells and Tissues.

Development of a mitochondrial sirtuin 4 FRET assay based on its activity for removing 3-hydroxy-3-methylglutaryl (HMG) modification